Przejdź do zawartości
Merck

Dietary lipids fuel GPX4-restricted enteritis resembling Crohn's disease.

Nature communications (2020-04-15)
Lisa Mayr, Felix Grabherr, Julian Schwärzler, Isabelle Reitmeier, Felix Sommer, Thomas Gehmacher, Lukas Niederreiter, Gui-Wei He, Barbara Ruder, Kai T R Kunz, Piotr Tymoszuk, Richard Hilbe, David Haschka, Clemens Feistritzer, Romana R Gerner, Barbara Enrich, Nicole Przysiecki, Markus Seifert, Markus A Keller, Georg Oberhuber, Susanne Sprung, Qitao Ran, Robert Koch, Maria Effenberger, Ivan Tancevski, Heinz Zoller, Alexander R Moschen, Günter Weiss, Christoph Becker, Philip Rosenstiel, Arthur Kaser, Herbert Tilg, Timon E Adolph
ABSTRAKT

The increased incidence of inflammatory bowel disease (IBD) has become a global phenomenon that could be related to adoption of a Western life-style. Westernization of dietary habits is partly characterized by enrichment with the ω-6 polyunsaturated fatty acid (PUFA) arachidonic acid (AA), which entails risk for developing IBD. Glutathione peroxidase 4 (GPX4) protects against lipid peroxidation (LPO) and cell death termed ferroptosis. We report that small intestinal epithelial cells (IECs) in Crohn's disease (CD) exhibit impaired GPX4 activity and signs of LPO. PUFAs and specifically AA trigger a cytokine response of IECs which is restricted by GPX4. While GPX4 does not control AA metabolism, cytokine production is governed by similar mechanisms as ferroptosis. A PUFA-enriched Western diet triggers focal granuloma-like neutrophilic enteritis in mice that lack one allele of Gpx4 in IECs. Our study identifies dietary PUFAs as a trigger of GPX4-restricted mucosal inflammation phenocopying aspects of human CD.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Arachidonic acid, from non-animal source, ≥98.5% (GC)
Sigma-Aldrich
β-Thujaplicin, 99%
Sigma-Aldrich
Cumene hydroperoxide, technical grade, 80%
Sigma-Aldrich
Bay 11-7082, ≥98% (HPLC), powder
Sigma-Aldrich
Arachidonic acid, >95.0% (GC)
Sigma-Aldrich
L-Glutathione reduced, ≥98.0%
Sigma-Aldrich
cis-5,8,11,14,17-Eicosapentaenoic acid, ≥99%
Sigma-Aldrich
Anti-Ferritin, Human antibody produced in rabbit, whole antiserum, liquid
Sigma-Aldrich
Oleic acid, ≥99% (GC)
Sigma-Aldrich
Glutathione Reductase from baker′s yeast (S. cerevisiae), ammonium sulfate suspension, 100-300 units/mg protein (biuret)
Sigma-Aldrich
cis-4,7,10,13,16,19-Docosahexaenoic acid, ≥98%
Sigma-Aldrich
Deoxycholic acid, ≥98% (HPLC)
Sigma-Aldrich
Sodium cholate hydrate, suitable for cell culture, BioReagent
Sigma-Aldrich
Anti-Actin antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Piroxicam, ≥98% (TLC)
Amersham Hybond® P Western blotting membranes, PVDF, pore size 0.45 μm, roll W × L 300 mm × 4 m, pkg of 1 ea
Sigma-Aldrich
Ferrostatin-1, ≥95% (HPLC)
Sigma-Aldrich
Ammonium sulfamate, BioXtra, ≥98.0%
Sigma-Aldrich
Stearidonic acid, ≥99%
Roche
Zestaw do wykrywania śmierci komórek in situ, POD, sufficient for ≤50 tests
Sigma-Aldrich
MISSION® esiRNA, targeting human GPX4
Sigma-Aldrich
Zileuton, ≥98% (HPLC)
Sigma-Aldrich
PD 146176, ≥98% (HPLC), solid
Sigma-Aldrich
2-(Diisopropylamino)ethyl methacrylate, 97%, contains ~100 ppm monomethyl ether hydroquinone as inhibitor
Supelco
Palmitoleic acid, analytical standard
Sigma-Aldrich
Palmitic acid, BioXtra, ≥99%
Sigma-Aldrich
all-cis-7,10,13,16,19-Docosapentaenoic acid, synthetic, ≥97%
Sigma-Aldrich
Ursodeoxycholic acid, ≥99%
Sigma-Aldrich
Deoxyribonuclease II from bovine spleen, Type V, essentially salt-free, lyophilized powder, ≥1,000 units/mg protein
Sigma-Aldrich
Lipopolysaccharides from Escherichia coli O55:B5, purified by ion-exchange chromatography, TLR ligand tested